rs1057517565
|
|
0.925 |
0.200 |
13 |
32338925 |
frameshift variant
|
TTTC/-
|
del
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
1.000 |
1 |
2016 |
2016 |
rs1057517565
|
|
0.925 |
0.200 |
13 |
32338925 |
frameshift variant
|
TTTC/-
|
del
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
1.000 |
1 |
2016 |
2016 |
rs1057517566
|
|
0.925 |
0.200 |
13 |
32337431 |
frameshift variant
|
AA/-
|
del
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057517566
|
|
0.925 |
0.200 |
13 |
32337431 |
frameshift variant
|
AA/-
|
del
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1057517572
|
|
0.925 |
0.200 |
13 |
32319315 |
frameshift variant
|
-/T
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057517572
|
|
0.925 |
0.200 |
13 |
32319315 |
frameshift variant
|
-/T
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1057517595
|
|
1.000 |
|
13 |
32339841 |
frameshift variant
|
GT/-
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057517636
|
|
1.000 |
|
13 |
32338829 |
stop gained
|
A/T
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057517865
|
|
1.000 |
|
13 |
32371025 |
stop gained
|
A/T
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057518635
|
|
1.000 |
|
13 |
32340367 |
frameshift variant
|
ATAG/-
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057518635
|
|
1.000 |
|
13 |
32340367 |
frameshift variant
|
ATAG/-
|
delins
|
|
|
Mammary Neoplasms
|
0.700 |
|
0 |
|
|
rs1057518637
|
|
1.000 |
|
13 |
32336621 |
stop gained
|
C/G;T
|
snv
|
|
|
Neoplastic Syndromes, Hereditary
|
0.700 |
1.000 |
1 |
2013 |
2013 |
rs1057518637
|
|
1.000 |
|
13 |
32336621 |
stop gained
|
C/G;T
|
snv
|
|
|
Mammary Neoplasms
|
0.700 |
|
0 |
|
|
rs1057518637
|
|
1.000 |
|
13 |
32336621 |
stop gained
|
C/G;T
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057518638
|
|
1.000 |
|
13 |
32339317 |
stop gained
|
T/A
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057518638
|
|
1.000 |
|
13 |
32339317 |
stop gained
|
T/A
|
snv
|
|
|
Mammary Neoplasms
|
0.700 |
|
0 |
|
|
rs1057519559
|
|
0.925 |
0.200 |
13 |
32339514 |
frameshift variant
|
AACA/-
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|
rs1057519559
|
|
0.925 |
0.200 |
13 |
32339514 |
frameshift variant
|
AACA/-
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1057520636
|
|
1.000 |
|
13 |
32338581 |
stop gained
|
T/A
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1060499566
|
|
1.000 |
|
13 |
32316421 |
splice acceptor variant
|
G/A
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1060499833
|
|
1.000 |
|
13 |
32339338 |
stop gained
|
T/G
|
snv
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1060502376
|
|
1.000 |
0.200 |
13 |
32319076 |
splice acceptor variant
|
G/A;C;T
|
snv
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
1.000 |
1 |
2010 |
2010 |
rs1060502376
|
|
1.000 |
0.200 |
13 |
32319076 |
splice acceptor variant
|
G/A;C;T
|
snv
|
|
|
Neoplastic Syndromes, Hereditary
|
0.700 |
|
0 |
|
|
rs1060502385
|
|
0.925 |
0.200 |
13 |
32332376 |
frameshift variant
|
GTA/TT
|
delins
|
|
|
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2
|
0.700 |
|
0 |
|
|
rs1060502385
|
|
0.925 |
0.200 |
13 |
32332376 |
frameshift variant
|
GTA/TT
|
delins
|
|
|
Hereditary Breast and Ovarian Cancer Syndrome
|
0.700 |
|
0 |
|
|